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Abstract
Streptococcus dysgalactiae ssp. equisimilis (SDSE) is increasingly being identiﬁed as a pathogen responsible for invasive and non-invasive
infections. We compared the clinical features of invasive SDSE infections with those of invasive infections caused by Streptococcus pyoge-
nes (group A streptococcus (GAS)) and Streptococcus agalactiae (group B streptococcus (GBS)). Active surveillance for invasive SDSE,
GAS and GBS was maintained over 1 year at 142 medical institutions throughout Japan. Clinical information was collected together with
isolates, which were characterized microbiologically. Two hundred and thirty-one invasive SDSE infections were identiﬁed, 97 other
patients had infections with GAS, and 151 had infections with GBS. The median age of the SDSE patients was 75 years; 51% were male
and 79% had underlying diseases. Forty-two SDSE patients (19%) presented to the emergency department. Among the 150 patients
(65%) for whom follow-up was completed, 19 (13%) died and eight (5%) had post-infective sequelae (poor outcome). Insufﬁcient white
blood cell responses (<5000 cells/lL) and thrombocytopenia on admission each suggested signiﬁcantly higher risk of poor outcome
(ORs 3.6 and 4.5, respectively). Of 229 isolates, 55 (24%) showed an stG6792 emm type, which was signiﬁcantly associated with poor
outcome (OR 2.4). Clinical manifestations of invasive SDSE infections were distinct from those of invasive GBS infections. Primary-care
doctors should consider invasive SDSE infections when treating elderly patients.
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Introduction
Invasive infections caused by b-haemolytic streptococci apart
from Lanceﬁeld groups A and B, as well as by Streptococcus
pyogenes (group A streptococcus (GAS)) and Streptococcus
agalactiae (group B streptococcus (GBS)), are reported
increasingly worldwide [1,2]. The other streptococci include
groups C, G, F and L; group G is notable because these
streptococci can cause bacteraemia [3,4]. According to pre-
vious investigations [5], this group includes Streptococcus dys-
galactiae ssp. equisimilis (SDSE), the Streptococcus anginosus
group, and Streptococcus canis.
Recently, SDSE isolates possessing group G antigen have
been recovered increasingly from severe invasive streptococ-
cal infections [6]. Brandt et al. [7] characterized blood cul-
ture isolates of SDSE possessing Lanceﬁeld group A antigen.
Infection with this pathogen (11 strains) was also sometimes
found to lead to streptococcal toxic shock syndrome [8].
We have just completed whole genome analyses of two ori-
ginal isolates (GGS_124 (GenBank accession number
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AP010935) and RE378) of SDSE, demonstrating a rate of
genome overlap between this subspecies and GAS of
61–63%, whereas the overlap between the subspecies and
GBS genomes was 15% (T. Akiyama, K. Ubukata & T. Kiri-
kae, unpublished data).
However, active nationwide surveillance with a collection
of large numbers of strains remains to be instituted, as for
many years SDSE was considered to be non-pathogenic. We
therefore collected isolates of this microorganism as well as
of GAS and GBS, with accompanying detailed clinical infor-
mation, from 142 medical institutions. Our aim was to com-
pare clinical aspects of invasive diseases caused by SDSE with
those caused by GAS or GBS in Japan.
Materials and Methods
Surveillance
Active laboratory-based surveillance for invasive SDSE, GAS
or GBS infections was organized by the Laboratory of
Molecular Epidemiology for Infectious Agents at the Gradu-
ate School of Infection Control Sciences, Kitasoto, Japan.
SDSE included some isolates of the Lanceﬁeld C or A
groups. We excluded S. anginosus group isolates that
showed group C, G or F antigen in the process of isolate
identiﬁcation.
Surveillance was conducted for 1 year (1 August 2006 to
31 July 2007) in 142 medical institutions participating in the
Invasive Streptococcal Disease Working Group established
at the 19th Annual Meeting of the Japanese Society for
Clinical Microbiology. Invasive streptococcal diseases were
deﬁned as conditions with isolation of organisms from a
normally sterile site (i.e. blood, cerebrospinal ﬂuid, joint
ﬂuid, ascites, or pleural effusion) [1,9,10]. Isolates were ﬁrst
identiﬁed as streptococci at local hospital laboratories, using
standard commercially available latex agglutination assays.
Detailed standardized categories of information regarding
clinical features (e.g. hospital departments of initial presen-
tation and underlying conditions) and laboratory ﬁndings
(e.g. white blood cell (WBC) count, platelet count and
C-reactive protein (CRP) serum concentration) were
obtained from medical charts for all subjects enrolled. Clini-
cal syndromes were assigned on the basis of physicians’
diagnoses recorded in the medical charts. Poor outcomes
were deﬁned as either death from invasive infections within
3 weeks of onset or invasive disease-associated sequelae
following the streptococcal infection (e.g. worsened paraly-
sis or bedridden status). All isolates were sent to the Labo-
ratory of Molecular Epidemiology for Infectious Agents to
determine additional characteristics, including Lanceﬁeld
group, species, M protein gene (emm) or capsular type, and
antibiotic susceptibility.
Laboratory methods
Isolates were characterized with standard biochemical and
enzymatic tests, and were identiﬁed as previously described
[11]. The emm types of SDSE or GAS isolates [12] and the
capsular types of GBS [13] isolates were determined as
previously reported. All emm typing was based on the
CDC database (ftp://ftp.cdc.gov/pub/infectious_diseases/biotech/
tsemm/). In addition, we quantiﬁed the susceptibility of
streptococci to 14 antibiotics, including oral and parenteral
antibiotics, by agar plate dilution methods using blood agar,
as previously described [10]. Depending on the MICs, the
presence of streptococcal genes associated with resis-
tance to antimicrobials (e.g. mef(A), erm(A), or erm(B)) was
determined. To assess the similarity of isolates, proﬁling
using pulsed-ﬁeld gel electrophoresis (PFGE) following DNA
treatment with the restriction enzyme SmaI was also
performed [10].
Statistical analysis
Microsoft Excel was used for data analysis. Patient or patho-
gen characteristics, clinical features and outcomes were com-
pared between paired groups of isolates (SDSE and GAS,
SDSE and GBS, or GAS and GBS), using the chi-squared test.
To identify clinical laboratory ﬁndings associated with fatal
outcome, ORs with 95% CIs and p-values according to the
chi-squared test were calculated.
Results
We identiﬁed 231 patients with invasive infection caused by
SDSE in the records from 142 medical institutions during the
1-year study period, during which time 97 GAS and 151 GBS
cases were also collected. All isolates of SDSE, GAS or GBS
were referred by the hospital laboratories for further micro-
biological characterization.
As shown in Fig. 1, the age distribution differed signiﬁ-
cantly between patients with invasive SDSE and those with
GBS infection. All patients (n = 231) with invasive SDSE
infection were adults, whereas GBS infected some patients
4 months old or younger in addition to adults, especially
the elderly. We therefore chose to compare clinical aspects
of invasive SDSE diseases with those caused by GAS
(n = 82) or GBS (n = 123) in the adult population
(‡15 years old).
Isolates (n = 12) of the S. anginosus group were excluded
from the current surveillance. Lanceﬁeld groups G, C and A,
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respectively, accounted for 216, 12 and three SDSE isolates.
All GAS or GBS isolates were S. pyogenes or S. agalactiae,
respectively.
Patient characteristics and clinical presentations according
to the streptococcal group (SDSE, GAS, or GBS)
Patient characteristics, clinical presentations and disease out-
comes for all invasive SDSE, GAS and GBS infections are
shown in Table 1. The median age of patients with SDSE dis-
eases was 75 years (range, 19–103 years), with the subjects
with SDSE infections being signiﬁcantly older than those with
GAS or GBS infections (p <0.01 for each). In our surveil-
lance, all cases of SDSE, GAS and GBS diseases were com-
munity-acquired. Forty-two patients (19%) with SDSE
infections presented to the hospital emergency department,
a fraction similar to those of the subjects presenting to the
emergency department with infections involving the other
two groups.
Underlying diseases were present in 79% of patients with
invasive SDSE illnesses; underlying medical conditions in sub-
jects with GAS infections were signiﬁcantly less frequent than
TABLE 1. Demographic characteristics, underlying conditions and clinical syndromes in patients with invasive infection caused
by Streptococcus dysgalactiae ssp. equisimilis (n = 231), Streptococcus pyogenes (n = 97), or Streptococcus agalactiae (n = 151)
Characteristic
No. (%) of patients p-Value
S. dysgalactiae
ssp. equisimilis (A) S. pyogenes (B) S. agalactiae (C) A vs. B A vs. C B vs. C
Demographic characteristic
Age (years)
<15 0 (0.0) 15 (15.5) 28 (18.5) <0.01 <0.01 0.53
15–39 10 (4.3) 18 (22.0) 13 (10.6) <0.01 0.02 0.03
40–64 50 (21.6) 32 (39.0) 39 (31.7) <0.01 0.04 0.28
‡65 171 (74.0) 32 (39.0) 71 (57.7) <0.01 <0.01 <0.01
Gendera,b
Male 117 (51.3) 40 (49.4) 55 (44.7) 0.77 0.24 0.51
Department where presenteda
Emergency 42 (19.3) 22 (26.8) 22 (18.0) 0.15 0.78 0.13
Internal medicine 112 (51.4) 36 (43.9) 73 (59.8) 0.25 0.13 0.03
Surgery 64 (29.4) 24 (29.3) 27 (22.1) 0.99 0.15 0.25
Poor outcomea
Death 19 (12.7) 12 (16.7) 8 (10.8) 0.42 0.69 0.30
Death or sequelae 27 (18.0) 19 (26.4) 11 (14.9) 0.15 0.56 0.08
Underlying diseasea
None 48 (21.2) 31 (39.7) 16 (11.8) <0.01 0.07 <0.01
Diabetes mellitus 36 (15.9) 12 (15.4) 22 (16.2) 0.64 0.92 0.72
Malignant disease 35 (15.5) 13 (16.7) 33 (24.3) 0.39 0.02 0.41
Stroke 28 (12.4) 0 (0.0) 5 (3.7) <0.01 <0.01 0.27
Heart disease 18 (8.0) 4 (5.1) 10 (7.4) 0.80 0.85 0.95
Pulmonary disease 2 (0.9) 0 (0.0) 0 (0.0) 0.93 0.72 –
Liver dysfunction 11 (4.9) 2 (2.6) 17 (12.5) 0.77 <0.01 0.03
Renal dysfunction 13 (5.8) 4 (5.1) 9 (6.6) 0.84 0.72 0.89
Artherosclerotic cardiovascular disease 8 (3.5) 1 (1.3) 11 (8.1) 0.66 0.05 0.12
Autoimmune disease 4 (1.8) 1 (1.3) 5 (3.7) 0.69 0.42 0.68
Other 23 (10.2) 10 (12.8) 8 (5.9)
Clinical syndrome
Sepsis without focus 98 (42.4) 27 (32.9) 77 (62.6) 0.06 <0.01 <.01
Cellulitis 52 (22.5) 23 (28.0) 12 (9.8) 0.43 <0.01 <.01
Septic arthritis 23 (10.0) 3 (3.7) 4 (3.3) 0.06 0.02 0.78
Pneumonia 12 (5.2) 6 (7.3) 8 (6.5) 0.74 0.64 0.87
Necrotizing fasciitis 9 (3.9) 5 (6.1) 1 (0.8) 0.67 0.18 0.08
Meningitis 5 (2.2) 3 (3.7) 3 (2.4) 0.79 0.82 0.97
Infectious endocarditis 4 (1.7) 0 (0.0) 4 (3.3) 0.51 0.60 0.24
Streptococcal toxic shock syndorome 2 (0.9) 3 (3.7) 0 (0.0) 0.25 0.76 0.13
Abscess (excluding skin) 2 (0.9) 8 (9.8) 3 (2.4) <0.01 0.48 0.06
Osteomyelitis 2 (0.9) 0 (0.0) 1 (0.8) 0.94 0.59 0.85
Other 22 (9.5)c 4 (4.9) 10 (8.1)
aPatients with unknown data were excluded.
bGender, department where presented, poor outcome, underlying disease and clinical syndrome in the adult population were compared between paired groups (S. dysgalacti-
ae ssp. equisimilis (SDSE) and group A streptococcus (GAS), SDSE and group B streptococcus (GBS), or GAS and GBS).
cOthers included urosepsis (n = 13), septic spondylitis (n = 4), endophthalmitis (n = 2), peritonitis (n = 2), and biliary tract infection (n = 1).
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FIG. 1. Number of patients with invasive infections caused by Strep-
tococcus dysgalactiae ssp. equisimilis (n = 231), Streptococcus pyogenes
(n = 97), and Streptococcus agalactiae (n = 151), shown by age group.
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in patients with SDSE or GBS infections (p <0.01 for each).
Among patients with SDSE infection, stroke was signiﬁcantly
more frequent than in patients with GAS or GBS infection
(p <0.01 for each), whereas in patients with GBS infection,
liver dysfunction was signiﬁcantly more prevalent than in
those with SDSE or GAS infection (p <0.01 and p = 0.03,
respectively). With regard to clinical syndromes, sepsis with-
out focus was signiﬁcantly more frequent among GBS-
infected than among SDSE-infected or GAS-infected patients
(p <0.01 for each), whereas cellulitis was signiﬁcantly less fre-
quent among GBS-infected patients than among SDSE-
infected or GAS-infected patients (p <0.01 for each). Sub-
jects infected with SDSE presented more often with septic
arthritis than those infected with GBS (p = 0.02), whereas
patients with GAS infections more often had abscesses
involving sites deeper than the skin than did patients with
SDSE infection (p <0.01).
Disease outcomes according to the streptococcal group
(SDSE, GAS, or GBS)
Among 150 patients (65%) with invasive SDSE diseases for
whom follow-up investigation was complete, 19 (13%) died,
and eight (5%) had post-infection sequelae. No signiﬁcant dif-
ference in frequency of poor outcome was evident among
the three groups. The median time from admission to death
was 3 days in subjects who died of SDSE infections, as com-
pared with 1 and 7 days, respectively, for fatalities caused by
GAS and GBS. Clinical laboratory data obtained at admission
(WBC and platelet counts and CRP serum concentrations)
for the three groups are shown in Table 2. In subjects with
SDSE infection, a poor WBC response (<5000 cells/lL) and
thrombocytopenia were associated with a signiﬁcantly higher
risk of poor outcome, with respective ORs of 3.6
(95% CI 1.2–11.5; p = 0.04) and 4.5 (95% CI 1.6–12.2;
p <0.01). These two ﬁndings were also signiﬁcantly related
to poor outcomes in patients with GAS infections, but not in
adults with GBS infections. There was no association of CRP
level with poor outcome in the three groups.
emm typing for the isolates from adults
emm typing was carried out for 231 SDSE isolates and for 82
of the 97 S. pyogenes isolates; capsular typing was performed
for 123 of the 151 S. agalactiae isolates. The incidences of
emm types among SDSE isolates are shown in Table 3. Inter-
estingly, emm type stG6792 in SDSE isolates, which was con-
ﬁrmed most frequently (n = 55, 24%), was signiﬁcantly
associated with poor outcome of invasive SDSE diseases in
comparison with other SDSE emm types, with an OR of 2.4
(95% CI 1.0–5.9; p = 0.04). Within the stG6792 type, most
isolates showed emm type stG6792.3 (n = 54), whereas
PFGE of the isolates of the stG6792.3 type revealed similar
proﬁles. On the other hand, among GAS isolates, emm
type 1 was found most frequently (n = 27, 33%). This type
was also signiﬁcantly related to poor outcome of invasive
infections, with an OR of 3.4 (95% CI 1.1–10.5; p 0.02).
Other emm types frequently found in GAS infections were
TABLE 2. Clinical laboratory ﬁndings associated with fatal outcome of invasive infections caused by Streptococcus dysgalactiae
ssp. equisimilis, Streptococcus pyogenes, or Streptococcus agalactiae
Median or percentage (25/75th percentiles) and (no./total)
Poor outcomea Without poor outcomea Analytical data (OR (95% CI)) p-Value
S. dysgalactiae ssp. equisimilis
WBC (/lL) 11 400 (3908–15 200) (22/27) 12 600 (7850–16 050) (107/123) 3.6 (1.2–11.5) 0.04
<5000/lL 27.3% (6/22) 9.3% (10/107)
PLT (104/lL) 11.1 (7.3–15.2) (21/27) 18.8 (12.3–24.5) (100/123) 4.5 (1.6–12.2) <0.01
<13.0 · 104/lL 66.7% (14/21) 13.0% (31/100)
C-reactive protein (mg/dL) 18.7 (12.3–26.8) (22/27) 4.9 (1.6–21.1) (103/123) 0.2 (0.03–1.8) 0.23
<1 mg/dL 4.5% (1/22) 17.5% (18/103)
S. pyogenes
WBC (/lL) 7200 (3800–19 075) (18/19) 10 300 (8000–15 015) (46/53) 4.2 (1.2–15.6) 0.04
<5000/lL 38.9% (7/18) 13.0% (6/46)
PLT (104/lL) 10.1 (7.4–16.5) (18/19) 19.4 (15.6–28.0) (46/53) 7.5 (2.2–25.8) <0.01
<13.0 · 104/lL 61.1% (11/18) 17.4% (8/46)
C-reactive protein (mg/dL) 22.1 (12.7–28.0) (17/19) 15.6 (5.4–24.6) (45/53) 0.6 (0.06–6.5) 0.89
<1 mg/dL 5.9% (1/17) 8.9% (4/45)
S. agalactiae
WBC (/lL) 14 350 (9200–17 225) (10/11) 11 600 (7800–15 150) (47/63) 1.2 (0.1–12.6) 0.64
<5000/lL 10.0% (1/10) 8.5% (4/47)
PLT (104/lL) 10.0 (7.7–18.9) (9/11) 17.9 (12.2–24.3) (46/63) 3.2 (0.7–14.1) 0.23
<13.0 · 104/lL 55.6% (5/9) 28.3% (13/46)
C-reactive protein (mg/dL) 6.7 (1.6–10.0) (9/11) 8.3 (1.1–19.0) (46/63) 1.2 (0.2–6.9) 0.78
<1 mg/dL 22.2% (2/9) 19.6% (9/46)
WBC, white blood cell count; PLT, platelet count.
aPatients with unknown data were excluded.
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49 (n = 12), 89 (n = 5), 11 (n = 4), 12 (n = 4), and 75
(n = 4), whereas emm types 12 and 6 predominated in our
study of non-invasive GAS infections (T. Wajima, S. Y. Mur-
ayama & K. Ubukata, unpublished data).
Capsular type Ib in GBS isolates were not associated with
poor outcome of invasive diseases. This type (n = 39) was
observed most frequently in adults. Other GBS capsular
types, i.e. V (n = 23), II (n = 15), III (n = 14), and Ia (n = 11),
were predominantly observed, showing distribution patterns
different from those found in the study of non-invasive GBS
infections.
Antibiotic susceptibility
Antibiotic susceptibility testing was performed for all isolates
of SDSE, GAS and GBS. Of 231 SDSE isolates, four had the
mef(A) gene, and 13 and six isolates had erm(A) and erm(B)
genes, respectively; the presence of the latter suggested a
high level of resistance to clarithromycin (MIC ‡64 mg/L). In
addition, two SDSE isolates showed resistance to ﬂuoroqui-
nolones, such as levoﬂoxacin (MIC ‡32 mg/L), based on sub-
stitutions in GyrA (Ser81 to Phe or Tyr) and ParC (Ser79 to
Tyr). No penicillin or cephalosporin resistance was observed.
Discussion
To the best of our knowledge, this is the ﬁrst nationwide
surveillance regarding invasive infections caused by SDSE in
Japan. The study demonstrates signiﬁcant differences in clini-
cal aspects, including prognosis, between disease entities
caused by SDSE, GAS and GBS. The mortality rate of inva-
sive SDSE diseases in our study (13%) was similar to those
previously described in other countries (8–18%) [1,5,14,15].
Host-protective factors, including WBCs, platelets, and
CRP, affect the severity and prognosis of infectious diseases,
especially those involving invasive pathogens. Disturbed hae-
mostasis is a central ﬁnding in severe S. pyogenes infection
that is associated with M protein-induced platelet activation
and thrombus formation [16]. In particular, microthrombi
are found both at the local site of infection and at distant
sites. Platelets are responsible for maintaining vascular
function and haemostasis. With regard to WBCs and CRP,
streptococcal erythrogenic toxin B induces apoptosis and
proliferation in human leukocytes [17]. Moreover, serial CRP
monitoring was found to alert physicians to complications
and predict outcome earlier than clinical signs or roentgeno-
grams in 63 children with acute haematogenous osteomyelitis
[18]. In our investigations, a poor WBC response
(<5000 cells/lL) and thrombocytopenia at admission each
showed a signiﬁcantly higher risk of poor outcome (death or
invasive disease-associated sequelae) in patients with invasive
SDSE or GAS infections. However, CRP could not predict
poor outcomes. We need to continue to examine associa-
tions between prognosis and host defence factors.
The M protein of S. pyogenes is a major bacterial virulence
factor that confers resistance to phagocytosis [19]. Recently,
analysis of the emm gene, which codes for the amino acid
sequence (variable region) at the N-terminal end of the
M protein, has often been used for molecular epidemiological
studies regarding outbreaks of invasive or non-invasive strep-
tococcal infections [20,21]. Data suggesting horizontal gene
transfer and recombination between the emm genes of SDSE
and GAS strains have been observed in clinical isolates from
seven subjects [21]. These genetic transfer and recombina-
tion events might have a role in pathogenesis. In our study,
emm type stG6792 in SDSE isolates (n = 55), the type most
frequently conﬁrmed in SDSE infection, was signiﬁcantly
more often associated with poor outcome of invasive dis-
eases than other SDSE emm types. In contrast to the high
frequency in our study, only three strains of stG6792 were
observed in a recent article from the USA [1]. Surveillance
periods for strains differed between Japan (2006–2007) and
the USA (2002–2004). On the basis of the CDC database
concerning emm type sequences, the stG6792.3 reference
strain appeared to be derived from a streptococcal isolate
from India, suggesting that this strain might have spread from
India to Japan. Similarly, the emm1 type in GAS isolates
(n = 27), the type that we found most frequently, was signiﬁ-
cantly related to poor outcome of invasive GAS infections.
Relationships between emm types and prognosis of the SDSE
and GAS infections in Japan should be investigated in an
ongoing manner. In addition, we need to determine person-
to-person transmission routes of SDSE, as the stG6792.3
TABLE 3. Types of emm for 231 cases of invasive infection
caused by Streptococcus dysgalactiae ssp. equisimilis
emm type
No. of isolates Poor outcome
(n = 231) (n = 27)
stG6792a 55 (23.8) 11
stG485 37 (16.0) 1
stG6 21 (9.1) 4
stG10 21 (9.1) 2
stG652 17 (7.4) 1
stG2078 16 (6.9) 2
stC36 15 (6.5) 1
stG245 13 (5.6) 2
stG5420 6 (2.6) 1
stG480 5 (2.2) 1
stC6979 5 (2.2) 0
stG4974 4 (1.7) 1
stG653 3 (1.3) 0
Other 11 (4.8) 0
Non-typeable 2 (0.9) 0
aThis emm type includes stG6792.3 (n = 54) and stG6792.0 (n = 1).
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strain (n = 54) was observed most frequently within the
stG6792 type, and similar SmaI digestion patterns were
found for the isolates using PFGE analysis.
Antibiotic susceptibility testing and resistance gene identiﬁ-
cation for SDSE isolates in our study revealed clarithromycin
and levoﬂoxacin resistance, as described by others [1,2,5].
On the other hand, susceptibility to b-lactam antibiotics,
including penicillin and cephalosporins, was high, suggesting
that they should be the usual drugs of choice.
Some limitations of our investigation should be noted.
Broyles et al. [1] recently reported an annual incidence of
invasive b-haemolytic streptococcal infections involving groups
other than A and B in the USA of 3.17 cases per 100 000
persons. Our surveillance, on the other hand, was not a
population-based study of the burden of infections caused by
SDSE, GAS and GBS, as ofﬁcial, systemic surveillance has not
yet been established in Japan. To our knowledge, however,
our study is the largest record of cases of invasive illness
caused by SDSE, GAS and GBS in Japan to date.
In our investigation, clinical aspects of invasive SDSE infec-
tions appear to differ from those caused by GBS, and to be
somewhat more similar to those caused by GAS. These
observations might be accounted for by our ﬁndings that
genes encoding virulence factors (e.g. M protein) in SDSE
could be partially shared with those in GAS, on the basis of
results of whole genome analyses of original SDSE isolates.
Moreover, clinical isolates of SDSE possessing group A anti-
gen have been reported [7]. SDSE has been established as a
possible component of the normal ﬂora of the skin, orophar-
ynx, and gastrointestinal and genitourinary tracts. We identi-
ﬁed SDSE in respiratory tract specimens from patients with
non-invasive SDSE diseases in another study (K. Sunaoshi,
S. Y. Murayama & K. Ubukata, unpublished data). However,
questions persist as to how SDSE invades deep tissues and
vessels. Further investigations to clarify this issue are
needed.
In conclusion, primary-care doctors, particularly those
treating patients in emergency departments, should consider
invasive diseases caused by SDSE, especially when treating
elderly subjects with underlying medical conditions.
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